Session Details
[S16]The-6th clinical chemistry opens up novel pharmacotherapeutic strategies ~Novel personalized medicines based on innovative biomarker tests~
Sat. Mar 26, 2022 4:00 PM - 6:00 PM JST
Sat. Mar 26, 2022 7:00 AM - 9:00 AM UTC
Sat. Mar 26, 2022 7:00 AM - 9:00 AM UTC
[Room E] Reception Hall Bldg. 1: 4F
Organizer: Hirofumi Jono (Dept. Pharm. Sci., Kumamoto Univ. Hosp.), Masamitsu Maekawa (Dept. Pharm. Sci., Tohoku Univ. Hosp.)
Clinical chemistry is a field that aims to contribute to the elucidation of pathophysiology and treatment / prevention, as well as the practice of providing clinical chemistry tests based on analytical technology to medical care. In the field of pharmaceutical care, personalized medicine based on therapeutic drug monitoring (TDM), genome analysis information, and therapeutic biomarkers finding using mass analysis technology have been investigated recently. And so, the latest knowledge and concepts of clinical chemistry based on clinical tests are becoming indispensable.
This symposium is co-sponsored by the Japan Society for Clinical Chemistry with the aim of contributing to the medical field of clinical chemistry. In this session, we would like to introduce and discuss the latest findings and topics under the theme of "Development of new personalized therapies and biomarker tests aiming for the possibility of fusion of clinical chemistry and pharmaceutical sciences, which is indispensable for the practice of effective drug treatment.
This symposium is co-sponsored by the Japan Society for Clinical Chemistry with the aim of contributing to the medical field of clinical chemistry. In this session, we would like to introduce and discuss the latest findings and topics under the theme of "Development of new personalized therapies and biomarker tests aiming for the possibility of fusion of clinical chemistry and pharmaceutical sciences, which is indispensable for the practice of effective drug treatment.
趣旨説明：前川 正充（東北大病院薬）
[S16-1]Novel Rapid Method for Identifying and Quantifying Pathogenic Bacteria within Four Hours of Blood Collection
○Hideki Niimi1 (1. Facl. Med., Toyama Univ.)
[S16-2]Clinical evaluation of an authorized medical equipment based on high performance liquid chromatography [LM1010] for measurement of drug concentration
○Kazutaka Oda1, Shota Uchino2, Kayo Kurogi2, Naoya Matsumoto2, Kou Yonemaru2, Hitomi Arakaki2, Taiki Katsume2, Kaho Matsuyama2, Tomomi Katanoda1, Koji Iwamura1, Hideyuki Saito1,2, Hirofumi Jono1,2 (1. Dept. Pharm., Kumamoto Univ. Hosp., 2. Grad. Sch. Pharm. Sci., Kumamoto Univ.)
[S16-3]Multi-dimensional HPLC analysis of chiral amino acids and the biomarker screening for kidney disease
○Kenji Hamase1 (1. Grad. Sch. Pharmaceut. Sci., Kyushu Univ.)
[S16-4]Biobank-based pharmacogenomics biomarker discovery and its application to drug therapy
○Masahiro Hiratsuka1,2,3,4 (1. TohokuUnivPharm, 2. Tohoku Univ Hosp Pharm, 3. Tohoku Univ ToMMo, 4. Tohoku Univ INGEM)
[S16-5]Identified the primary S-nitrosylated site in protein disulfide isomerase
○Jiro Ogura1,2,4, Lloyd Ruddock2, Hiroki Sugiura3, Shinji Ono3, Nariyasu Mano3,4, Hiroaki Yamaguchi1,3,4 (1. Dept. of Pharm., Yamagata Univ. Hosp., 2. Oulu Univ. Fac. of Biochem. & Mol. Med., 3. Grad. Sch. Pharmaceut. Sci., Tohoku Univ., 4. Dept. of Pharm. Sci., Tohoku Univ. Hosp.)